Patients with a terminal illness would have expanded access to investigational drugs under Senate legislation that has been given preliminary approval by the House of Delegates. The bill would allow manufacturers to supply the medicine when all other treatment options have been exhausted. And as Virginia Public Radio’s Anne Marie Morgan reports, the legislation—which has been dubbed the “Right to Try” bill—was inspired by a young boy in the Commonwealth who fought for access to an investigational drug last year.


